Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)

Phase 4

• Conditions: Attention Deficit Hyperactivity Disorder
• Interventions: Drug: Methylphenidate

• Registration Number: NCT00862108
• Lead Sponsor: Seoul National University Hospital

Brief Summary

The purpose of this study is to determine whether norepinephrine gene polymorphism affect to treatment response in ADHD

Detailed Description

Not available

Study Timeline

• Study Start: 2008-09
• Study First Submitted: 2009-03-05
• Study First Submitted QC: 2009-03-13
• Study First Posted: 2009-03-16
• Status Verified: 2009-09
• Last Update Submitted: 2009-09-20
• Last Update Posted: 2009-09-22
• Primary Completion: 2010-03
• Study Completion: 2010-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• diagnosis made by DSM-IV and K-SADS-PL
• IQ > 71

Exclusion Criteria

• genetic disorder
• history of acquired brain injury
• seizure disorder
• other neurologic disorder
• mental disorder, pervasive developmental disorder
• obsessive-Compulsive disorder
• communication disorder
• learning disorder

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Methylphenidate	Methylphenidate	-

Primary Outcome Measures

Name	Time	Method
Clinical Global Impression Scale-Improvement	8 weeks

Secondary Outcome Measures

Name	Time	Method
ADHD rating scale	8 weeks

Trial Locations

Locations (1)

Seoul National University Hospital; 🇰🇷 Seoul, Korea, Republic of